Glenmark recalling around 2.17 lakh cartons of Estradiol Vaginal inserts in US

11 Nov 2019 Evaluate

Glenmark Pharmaceuticals has initiated recalling of close to 2.17 lakh cartons of Estradiol Vaginal inserts in the US market due to faulty delivery system.

As per the latest Enforcement Report by the US Food and Drug Administration (USFDA), Glenmark Pharmaceuticals Inc USA is recalling the product in various strengths which was manufactured at the company's Goa manufacturing facility. The ongoing voluntary class II recall is on account of a defective delivery system with complaints for the difficulty in pushing the plunger of the applicator.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).

Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×